C3 GLOMERULOPATHY

Clinical trials for C3 GLOMERULOPATHY explained in plain language.

Never miss a new study

Get alerted when new C3 GLOMERULOPATHY trials appear

Sign up with your email to follow new studies for C3 GLOMERULOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 2

New study to analyze Real-World use of iptacopan for rare kidney disease

Knowledge-focused Not yet recruiting

This study looks at medical records of 83 adults with C3 glomerulopathy (a rare kidney disease) who are taking the drug iptacopan. Researchers will describe patients' health history, lab results, and how their disease changes over a year. The goal is to learn more about the types…

Matched conditions: C3 GLOMERULOPATHY

Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused

Last updated May 13, 2026 16:01 UTC

C3 GLOMERULOPATHY

Get alerted when new C3 GLOMERULOPATHY trials appear

New study to analyze Real-World use of iptacopan for rare kidney disease